Drugs / TIL injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06088472 | Apr 2021 → Dec 2027 expected | — | Grit Biotechnology | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIL injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06088472 ↗ |
| Modality | Cell therapy | “Autologous tumor infiltrating lymphocyte injection” NCT06088472 ↗ |